Buy Biogen as stock looks ‘too good to ignore,’ Wells Fargo says

Investors are underestimating Biogen’s Alzheimer’s drug and some of its other key businesses, according to Wells Fargo.

2022 was like a reset for the

In this article AAPL Follow your favorite stocksCREATE FREE

While the excitement around artificial intelligence has